论文部分内容阅读
目的:目的观察米非司酮联合利凡诺终止瘢痕子宫中期妊娠引产的临床观察。方法:收集我院2009年1月～2012年12月间疤痕子宫中期妊娠要求终止妊娠的孕妇46例,随机分成2组,观察组26例为米非司酮联合利凡诺引产,对照组20例单用羊膜腔内利凡诺注射引产。结果:观察2组宫缩发动时间,胎儿娩出时间,胎盘娩出情况,产后出血量,软产道损伤及引产成功率,清宫率等方面均低于对照组。结论:米非司酮联合利凡诺用于剖宫产中期妊娠引产临产效果显著,方法安全,缩短产程,减少产后出血量,减少软产道损伤,可提高引产成功率。
Objective: To observe the clinical observation of mifepristone and rivanol to terminate abortion induced by mid-term pregnancy of scar. Methods: Forty-six pregnant women who were asked to terminate pregnancy during the second trimester of uterine scar pregnancy from January 2009 to December 2012 were randomly divided into two groups. Twenty-six patients in the observation group were induced by mifepristone and rivanol. The control group 20 Cases of single intra-amniotic rivanol injection induced abortion. Results: The duration of uterine contractions, the time of delivery of the fetus, the delivery of the placenta, the amount of postpartum hemorrhage, the injury of the soft birth canal and the success rate of induced labor were all observed in two groups, which were lower than those in the control group. Conclusion: Mifepristone combined with rivanol is effective in inducing abortion in mid-term pregnancy with cesarean section. The method is safe, shortens the labor process, reduces the amount of postpartum hemorrhage, reduces the injury of soft birth canal and improves the success rate of induction of labor.